Accepted for/Published in: JMIR Research Protocols
Date Submitted: Apr 8, 2021
Open Peer Review Period: Apr 1, 2021 - Apr 14, 2021
Date Accepted: May 18, 2021
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Randomized Control Trial for Evaluating the Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER): Protocol of an eHealth Approach for Pre-surgical Hip Replacement Education
ABSTRACT
Background. Osteoarthritis (OA), leading to hip replacement (THR), is a primary contributor to global mobility impairment. In 2018, more than 59K THR surgeries were performed in Canada. Health promotion education, such as prehabilitation, are vital to optimizing surgical outcomes. Purpose. To evaluate the feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER), an eHealth approach for prehabilitation education. Method. An assessor-masked, 2-arm feasibility randomized controlled trial (RCT) will be conducted. Forty (HIPPER group= 20 and control group= 20) older adults with hip OA, on a waitlist for a THR will be recruited. The HIPPER intervention consists of 12 online, interactive modules. The control group is usual practice consisting of 2 x 2 hour online educational sessions (webinars). Feasibility outcomes (e.g., recruitment and retention rates) will be evaluated. Implications. Results will lead to refinement of the HIPPER protocol in order to evaluate a standardized, and geographically accessible prehabilitation program.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.